Send to:

Choose Destination
See comment in PubMed Commons below
Diabet Med. 1996 Sep;13(9 Suppl 6):S148-50.

Effects of troglitazone on insulin sensitivity.

Author information

  • 1Department of Medicine, University of California, San Diego, La Jolla 92093, USA.


Studies to date confirm that troglitazone has therapeutic benefits to NIDDM and can normalize IGT in those individuals at increased risk of developing NIDDM. Hyperinsulinaemia is reduced by such treatment in association with reduced insulin resistance and there are favourable effects on blood pressure with troglitazone therapy as well. Since insulin resistance and hyperinsulinaemia are usually present in obesity and impaired glucose tolerance (IGT), troglitazone may be useful in preventing the development of NIDDM in these susceptible populations.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk